MORSY, S., ISMAIL, M., GHALLAB, M. (2021). SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL. test, 51(2), 365-370. doi: 10.21608/jesp.2021.193317
SALWA M. MORSY; MOUSA A. M. ISMAIL; MARWA M. I. GHALLAB. "SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL". test, 51, 2, 2021, 365-370. doi: 10.21608/jesp.2021.193317
MORSY, S., ISMAIL, M., GHALLAB, M. (2021). 'SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL', test, 51(2), pp. 365-370. doi: 10.21608/jesp.2021.193317
MORSY, S., ISMAIL, M., GHALLAB, M. SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL. test, 2021; 51(2): 365-370. doi: 10.21608/jesp.2021.193317